| Dr Ellen Lille Ellsworth, OD | |
|
9930 Johnnycake Ridge Rd, Suite 4b, Mentor, OH 44060-6752 | |
| (440) 352-8031 | |
| (440) 352-7671 |
| Full Name | Dr Ellen Lille Ellsworth |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 33 Years |
| Location | 9930 Johnnycake Ridge Rd, Mentor, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437297264 | NPI | - | NPPES |
| 0841316 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4277 T228 (Ohio) | Primary |
| Provider Name | Ellen L. Ellsworth, Od Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1568642890 PECOS PAC ID: 3274653704 Enrollment ID: O20120113000396 |
News Archive
President Obama took time out of his Hawaiian vacation on Sunday to sign into law one of the surprise accomplishments of the lame-duck Congress: a measure covering the cost of medical care for rescue workers and others sickened by toxic fumes and dust after the 2001 terrorist attack on the World Trade Center (Stolberg, 1/2).
When will RNAi therapies reach the market? Visiongain's brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.
Sinovac Biotech Ltd. has announced that it has received a revised Drug Supplementary Application Approval for Panflu, Sinovac's pandemic influenza vaccine from the China State Food and Drug Administration (SFDA), based on the Phase IIb clinical trial, Under the revised approval, the age group eligible for use of the whole viron inactivated pandemic influenza vaccine was expanded to 18 years old and over, whereas it was previously 18 to 60 years of age, enabling Sinovac to reach a much broader percentage of the population.
Facebook could be the key to helping mothers overcome breastfeeding challenges. That's according to a new study from the University of Georgia.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that third quarter consolidated net loss from continuing operations attributable to Safeguard common shareholders was $11.6 million, or $0.57 per share, compared with a net loss of $4.1 million, or $0.20 per share, in the same period of 2008.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ellen Lille Ellsworth, OD 9930 Johnnycake Ridge Rd, Suite 4b, Mentor, OH 44060-6752 Ph: (440) 352-8031 | Dr Ellen Lille Ellsworth, OD 9930 Johnnycake Ridge Rd, Suite 4b, Mentor, OH 44060-6752 Ph: (440) 352-8031 |
News Archive
President Obama took time out of his Hawaiian vacation on Sunday to sign into law one of the surprise accomplishments of the lame-duck Congress: a measure covering the cost of medical care for rescue workers and others sickened by toxic fumes and dust after the 2001 terrorist attack on the World Trade Center (Stolberg, 1/2).
When will RNAi therapies reach the market? Visiongain's brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.
Sinovac Biotech Ltd. has announced that it has received a revised Drug Supplementary Application Approval for Panflu, Sinovac's pandemic influenza vaccine from the China State Food and Drug Administration (SFDA), based on the Phase IIb clinical trial, Under the revised approval, the age group eligible for use of the whole viron inactivated pandemic influenza vaccine was expanded to 18 years old and over, whereas it was previously 18 to 60 years of age, enabling Sinovac to reach a much broader percentage of the population.
Facebook could be the key to helping mothers overcome breastfeeding challenges. That's according to a new study from the University of Georgia.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that third quarter consolidated net loss from continuing operations attributable to Safeguard common shareholders was $11.6 million, or $0.57 per share, compared with a net loss of $4.1 million, or $0.20 per share, in the same period of 2008.
› Verified 2 days ago
Sandra K Jones, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7200 Mentor Ave, Mentor, OH 44060 Phone: 440-946-8809 Fax: 440-269-7942 | |
Dr. Robert M Cherne, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9000 Mentor Ave Ste 102, Mentor, OH 44060 Phone: 216-383-0100 Fax: 216-383-6481 | |
Dr. Donald James Hendley, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9303 Mentor Avenue, Mentor, OH 44060 Phone: 440-974-3303 | |
Dr. Jocelyn Rose Pettitt, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7200 Mentor Ave, Mentor, OH 44060 Phone: 440-946-8809 Fax: 440-269-7942 | |
Great Lakes Eyecare, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 7348 Mentor Ave, Mentor, OH 44060 Phone: 440-953-2020 Fax: 440-953-2030 | |
Prof. Robert Waldman, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 8900 Mentor Ave, Suite B, Mentor, OH 44060 Phone: 440-255-7727 | |
Dr. Kenneth Andrew Boyle Sr., OD Optometrist Medicare: Medicare Enrolled Practice Location: 7875 Johnny Cake Ridge Rd, Great Lakes Mall, Mentor, OH 44060 Phone: 440-255-2176 Fax: 440-255-1094 |